All Stories

  1. Optimization of Extraction of Phlorotannins from the Arctic Fucus vesiculosus Using Natural Deep Eutectic Solvents and Their HPLC Profiling with Tandem High-Resolution Mass Spectrometry
  2. Cytotoxic Activity and Phytochemical Screening of Eco-Friendly Extracted Flavonoids from Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep and Trifolium pratense L. Flowers Using HPLC-DAD-MS/HRMS
  3. Mesomeric Betaines Based on Adamantylated 1,2,4‐Triazolo[4,3‐ a ]pyrimidin‐5‐ones: Synthesis, Structure and Conversion into Anionic N‐Heterocyclic Carbenes
  4. Comparison of Photophysical Properties of Lanthanide(III) Complexes of DTTA- or DO3A-Appended Aryl-2,2′-Bipyridines
  5. Phytochemical screening and properties of botanical crude extracts and ethyl acetate fractions isolated by deep eutectic solvent
  6. Acute behavioral and Neurochemical Effects of Novel N-Benzyl-2-Phenylethylamine Derivatives in Adult Zebrafish
  7. N,O-bidentate ligands-based salicylic spiroborates: A bright frontier of bioimaging
  8. Antioxidant and Cytotoxic Activities of Kudzu Roots and Soy Molasses against Pediatric Tumors and Phytochemical Analysis of Isoflavones Using HPLC-DAD-ESI-HRMS
  9. Potential of chromatography and mass spectrometry for the differentiation of three series of positional isomers of 2‐(dimethoxyphenyl)‐ N ‐(2‐halogenobenzyl)ethanamines
  10. Selective Synthesis of Azoloyl NH-1,2,3-Triazoles and Azolyl Diazoketones: Experimental and Computational Insights
  11. Identification of 4F-MDMB-BINACA metabolites in human blood and urine with LC-QTOF
  12. Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine (25H-NBF) Positional Isomers
  13. Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking
  14. Psychopharmacological characterization of an emerging drug of abuse, a synthetic opioid U-47700, in adult zebrafish
  15. Photophysics, photochemistry and bioimaging application of 8-azapurine derivatives
  16. Tentative identification of the phase I and II metabolites of two synthetic cathinones, MDPHP and α‐PBP, in human urine
  17. Synthesis and determination of analytical characteristics and differentiation of positional isomers in the series of N ‐(2‐methoxybenzyl)‐2‐(dimethoxyphenyl)ethanamine using chromatography–mass spectrometry
  18. Water-soluble luminescent lanthanide complexes based on C6-DTTA-appended 5-aryl-2,2′-bipyridines
  19. Development and Validation of a Gas Chromatographic Method for Quantitative Determination of the Active Ingredient in Phenyl Salicylate Drug Substance
  20. DARK Classics in Chemical Neuroscience: Kava
  21. Identification and analytical characterization of the synthetic cathinone N ‐butylhexedrone
  22. Stable Isotope-Labeled Azoloazines. Synthesis of a 13С and 15N Isotope-Enriched Derivative of Pyrazolo[5,1-c][1,2,4]Triazine –Potential Antidiabetic Agent
  23. Tentative identification of the metabolites of (1‐(cyclohexylmethyl)‐1 H ‐indol‐3‐yl)‐(2,2,3,3‐tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods
  24. When fish take a bath: Psychopharmacological characterization of the effects of a synthetic cathinone bath salt ‘flakka’ on adult zebrafish
  25. DARK Classics in Chemical Neuroscience: Arecoline
  26. DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
  27. DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone (“Flakka”)
  28. Elucidation of the Chemical Structure of a Gas Chromatographic Artifact of Synthetic Cannabinoid N-(1-Carbamoyl-2-Methylpropyl)-1-(Cyclohexylmethyl)-1H-Indazol-3Ccarboxamide by High-Resolution Mass Spectrometry
  29. Distinguishing of 2-MAPB and 6-MAPB: Solution of the problem
  30. Effects of a non-competitive N-methyl-d-aspartate (NMDA) antagonist, tiletamine, in adult zebrafish
  31. On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances
  32. Mass spectrometric properties ofN-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof
  33. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances
  34. Cannabinoids: structures, effects, and classification
  35. Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group
  36. Synthetic cannabinoids as designer drugs: New representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data
  37. 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: Chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures
  38. New Synthetic Cannabinoid – Methyl 2-{[1-(5-Fluoro-Pentyl)-3-Methyl-1H-Indol-3-Ylcarbonyl]-Amino}Butyrate – as a Designer Drug
  39. Analytical characterization of some synthetic cannabinoids, derivatives of indole-3-carboxylic acid
  40. Erratum to “Analytical characterization of some synthetic cannabinoids, derivatives of indole-3-carboxylic acid” [Forensic Sci. Int. 232 (2013) 1–10]
  41. Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety
  42. Anomalous rearrangement of 1,2,3-thiadiazoles to 1,2,3-triazoles
  43. Bromination of 2-thiazolylhydrazones
  44. Synthesis and transformations of 2-amino-1,3,4-thiadiazines